Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P J Podrid

Showing results (81-90 of 104) with videos related to

Pageof 11
Sort By:
Pacing and Clinical Electrophysiology : PACE|August 1, 1988
Therapeutic and diagnostic benefits of intentional crosstalk mediated ventricular output inhibitionP A Levine, F J Venditti, P J Podrid, et al.
The American Journal of Cardiology|October 16, 1987
Considerations of current methods for drug selection in treating malignant ventricular arrhythmiasB Lown, P J Podrid, T B Graboys, et al.
The American Journal of Cardiology|January 1, 1986
Daily reproducibility of electrophysiologic test results in malignant ventricular arrhythmiaF Lombardi, J Stein, P J Podrid, et al.
Circulation|February 1, 1986
Historic perspectives--electrical stimulation of the heartB Lown, T B Graboys, P J Podrid, et al.
Journal of the American College of Cardiology|February 1, 1986
Mexiletine and tocainide: does response to one predict response to the other?M Hession, R Blum, P J Podrid, et al.
The American Journal of Cardiology|April 1, 1988
Determinants of survival in patients with malignant ventricular arrhythmia associated with coronary artery diseaseS Lampert, B Lown, T B Graboys, et al.
The American Journal of Cardiology|April 30, 1987
Aggravation of arrhythmia by antiarrhythmic drugs--incidence and predictorsP J Podrid, S Lampert, T B Graboys, et al.
American Heart Journal|July 1, 1987
Predictors of antiarrhythmic drug efficacy in patients with malignant ventricular tachyarrhythmiasS H Hohnloser, E A Raeder, P J Podrid, et al.
Lancet (London, England)|June 15, 1974
Drug-associated diarrhoea as a potential reservoir for hospital infectionsR S Holzman, A L Florman, P J Podrid, et al.
Circulation|January 1, 1986
Short- and long-term therapy with tocainide for malignant ventricular tachyarrhythmiasS H Hohnloser, H W Lange, E A Raeder, et al.
Pageof 11

Showing results (81-90 of 104) with videos related to

Sort By:
Pageof 11
Pacing and Clinical Electrophysiology : PACE|August 1, 1988
Therapeutic and diagnostic benefits of intentional crosstalk mediated ventricular output inhibitionP A Levine, F J Venditti, P J Podrid, et al.
The American Journal of Cardiology|October 16, 1987
Considerations of current methods for drug selection in treating malignant ventricular arrhythmiasB Lown, P J Podrid, T B Graboys, et al.
The American Journal of Cardiology|January 1, 1986
Daily reproducibility of electrophysiologic test results in malignant ventricular arrhythmiaF Lombardi, J Stein, P J Podrid, et al.
Circulation|February 1, 1986
Historic perspectives--electrical stimulation of the heartB Lown, T B Graboys, P J Podrid, et al.
Journal of the American College of Cardiology|February 1, 1986
Mexiletine and tocainide: does response to one predict response to the other?M Hession, R Blum, P J Podrid, et al.
The American Journal of Cardiology|April 1, 1988
Determinants of survival in patients with malignant ventricular arrhythmia associated with coronary artery diseaseS Lampert, B Lown, T B Graboys, et al.
The American Journal of Cardiology|April 30, 1987
Aggravation of arrhythmia by antiarrhythmic drugs--incidence and predictorsP J Podrid, S Lampert, T B Graboys, et al.
American Heart Journal|July 1, 1987
Predictors of antiarrhythmic drug efficacy in patients with malignant ventricular tachyarrhythmiasS H Hohnloser, E A Raeder, P J Podrid, et al.
Lancet (London, England)|June 15, 1974
Drug-associated diarrhoea as a potential reservoir for hospital infectionsR S Holzman, A L Florman, P J Podrid, et al.
Circulation|January 1, 1986
Short- and long-term therapy with tocainide for malignant ventricular tachyarrhythmiasS H Hohnloser, H W Lange, E A Raeder, et al.
Pageof 11